Tilray Brands (NASDAQ:TLRY) remains a cautious investment, according to Zuanic & Associates, despite its solid balance sheet and diverse global assets. With a “Neutral” rating, Zuanic views Tilray as a long-term player in the cannabis sector, though short-term uncertainties cloud its outlook. Tilray’s international presence is expanding, notably in Germany, where sales have grown 50%. Yet, headwinds persist, including high operating expenses, rising share count and ongoing market share losses in Canada where Tilray has opted against aggressive discounting in certain product categories. Get Ben…